|
US7825121B2
(en)
|
1999-05-04 |
2010-11-02 |
Schering Corporation |
Piperazine derivatives useful as CCR5 antagonists
|
|
ATE466009T1
(de)
*
|
2001-03-29 |
2010-05-15 |
Schering Corp |
Ccr5 antagonisten verwendbar für die behandlung von aids
|
|
NZ528011A
(en)
|
2001-03-29 |
2004-08-27 |
Schering Corp |
Aryl oxime-piperazines useful as CCR5 antagonists
|
|
CN1596254A
(zh)
*
|
2001-11-29 |
2005-03-16 |
先灵公司 |
含有增加量的旋转异构体的药物活性盐的组合物的制备方法
|
|
EP2311818B1
(en)
|
2002-02-28 |
2013-01-16 |
Novartis AG |
Combination of a 5-phenylthiazole compound as PI3 kinase inhibitor with an antiinflammatory, bronchodilatory or antihistamine drug
|
|
JP4671091B2
(ja)
*
|
2002-03-18 |
2011-04-13 |
東レ・ファインケミカル株式会社 |
１−置換−２−メチルピペラジンの製造方法
|
|
MXPA04009428A
(es)
*
|
2002-03-29 |
2005-01-25 |
Schering Corp |
Sintesis de compuestos de piperidina y piperazina como antagonistas de ccr5.
|
|
US6872826B2
(en)
*
|
2002-03-29 |
2005-03-29 |
Schering Corporation |
Stereoselective alkylation of chiral 2-methyl-4-protected piperazines
|
|
US20050245537A1
(en)
*
|
2002-04-24 |
2005-11-03 |
Noboru Tsuchimori |
Use of compounds having ccr antagonism
|
|
JP2003335737A
(ja)
|
2002-05-21 |
2003-11-28 |
Central Glass Co Ltd |
光学活性（ｒ）−１−（４−トリフルオロメチルフェニル）エチルアミン
|
|
US7132539B2
(en)
*
|
2002-10-23 |
2006-11-07 |
The Procter & Gamble Company |
Melanocortin receptor ligands
|
|
US20060251651A1
(en)
*
|
2002-12-13 |
2006-11-09 |
Ono Pharmaceutical Co., Ltd. |
Antagonist and agonist which bind to a strong binding site of chemokine receptor
|
|
PE20040769A1
(es)
*
|
2002-12-18 |
2004-11-06 |
Schering Corp |
Derivados de piperidina utiles como antagonisas ccr5
|
|
JP4736043B2
(ja)
|
2003-03-14 |
2011-07-27 |
小野薬品工業株式会社 |
含窒素複素環誘導体およびそれらを有効成分とする薬剤
|
|
US20070043079A1
(en)
*
|
2003-04-18 |
2007-02-22 |
Hiromu Habashita |
Heterocyclic compound containing nitrogen atom and use thereof
|
|
EP1619193A4
(en)
|
2003-04-18 |
2010-08-11 |
Ono Pharmaceutical Co |
SPIROPIPERIDINE COMPOUND AND MEDICINAL USE THEREOF
|
|
AR044519A1
(es)
|
2003-05-02 |
2005-09-14 |
Novartis Ag |
Derivados de piridin-tiazol amina y de pirimidin-tiazol amina
|
|
GB0313661D0
(en)
*
|
2003-06-13 |
2003-07-16 |
Avecia Ltd |
Process
|
|
EP1633737A1
(en)
*
|
2003-06-13 |
2006-03-15 |
Schering Aktiengesellschaft |
Quinolyl amide derivatives as ccr-5 antagonists
|
|
WO2005005419A1
(en)
|
2003-06-30 |
2005-01-20 |
Schering Corporation |
Mch antagonists for the treatment of obesity
|
|
AU2004285051A1
(en)
|
2003-11-03 |
2005-05-12 |
Schering Corporation |
Bipiperidinyl derivatives useful as inhibitors of chemokine receptors
|
|
GB0329284D0
(en)
*
|
2003-12-18 |
2004-01-21 |
Avecia Ltd |
Process
|
|
GB0401334D0
(en)
|
2004-01-21 |
2004-02-25 |
Novartis Ag |
Organic compounds
|
|
EP1725235B1
(en)
*
|
2004-02-05 |
2009-04-15 |
Schering Corporation |
Piperidine derivatives useful as ccr3 antagonists
|
|
EP1716156A2
(en)
*
|
2004-02-10 |
2006-11-02 |
F.Hoffmann-La Roche Ag |
Chemokine ccr5 receptor modulators
|
|
BRPI0508140B1
(pt)
|
2004-03-05 |
2015-03-17 |
Nissan Chemical Ind Ltd |
Composto benzamida substituída por isoxazolina da fórmula (1); da fórmula (2) substituído por 3,5-bis (aril substituído); da fórmula (4) substituída por alquinibenzeno ou um sal do mesmo; "pesticida, agroquímico, inseticida, parasiticida contendo como ingrediente ativo um ou mais composto benzamida substituída por isoxazolina e sal do mesmo"
|
|
ES2431524T3
(es)
*
|
2004-04-13 |
2013-11-26 |
Incyte Corporation |
Derivados de piperazinilpiperidina como antagonistas de los receptores de quimiocinas
|
|
ATE382623T1
(de)
|
2004-06-09 |
2008-01-15 |
Hoffmann La Roche |
Octahydropyrrolo(3,4-c)pyrrolderivate und deren verwendung als antivirale mitteln
|
|
GB0417804D0
(en)
*
|
2004-08-10 |
2004-09-15 |
Novartis Ag |
Organic compounds
|
|
AU2005283326B2
(en)
|
2004-09-13 |
2011-07-21 |
Ono Pharmaceutical Co., Ltd. |
Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient
|
|
GT200500281A
(es)
|
2004-10-22 |
2006-04-24 |
Novartis Ag |
Compuestos organicos.
|
|
GB0426164D0
(en)
|
2004-11-29 |
2004-12-29 |
Novartis Ag |
Organic compounds
|
|
US7700597B2
(en)
|
2004-12-03 |
2010-04-20 |
Schering Corporation |
Substituted piperazines as CB1 antagonists
|
|
US7635698B2
(en)
|
2004-12-29 |
2009-12-22 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as chemokine receptor antagonists
|
|
WO2006071875A1
(en)
|
2004-12-29 |
2006-07-06 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as chemokine receptor antagonists
|
|
CN101133048A
(zh)
*
|
2005-01-06 |
2008-02-27 |
先灵公司 |
哌嗪化合物的药用盐制备
|
|
US7566718B2
(en)
|
2005-02-16 |
2009-07-28 |
Schering Corporation |
Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity
|
|
AU2006214378A1
(en)
*
|
2005-02-16 |
2006-08-24 |
Pharmacopeia, Inc. |
Pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity
|
|
CA2598458A1
(en)
|
2005-02-16 |
2006-08-24 |
Schering Corporation |
Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity
|
|
CN101189238A
(zh)
*
|
2005-02-16 |
2008-05-28 |
先灵公司 |
具有cxcr3拮抗剂活性的哌嗪-哌啶
|
|
JP2008530216A
(ja)
|
2005-02-16 |
2008-08-07 |
シェーリング コーポレイション |
Ｃｘｃｒ３アンタゴニスト活性を有する、複素環で置換された新規のピリジンまたはフェニル化合物
|
|
KR20070107085A
(ko)
*
|
2005-02-23 |
2007-11-06 |
쉐링 코포레이션 |
케모카인 수용체의 억제제로서 유용한 피페리디닐 피페라진유도체
|
|
GB0507577D0
(en)
|
2005-04-14 |
2005-05-18 |
Novartis Ag |
Organic compounds
|
|
GB0510390D0
(en)
|
2005-05-20 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
|
EP1889622A4
(en)
|
2005-05-31 |
2009-12-23 |
Ono Pharmaceutical Co |
SPIROPIPERIDINE COMPOUND AND MEDICINAL USE THEREOF
|
|
BRPI0611138A2
(pt)
|
2005-06-02 |
2010-08-17 |
Hoffmann La Roche |
compostos, processo para a manufatura dos mesmos, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades que estão associadas com a modulação de receptores de sst subtipo 5 e utilização dos compostos
|
|
US7665658B2
(en)
|
2005-06-07 |
2010-02-23 |
First Data Corporation |
Dynamic aggregation of payment transactions
|
|
EP1940781A1
(en)
|
2005-10-19 |
2008-07-09 |
F.Hoffmann-La Roche Ag |
Phenyl-acetamide nnrt inhibitors
|
|
EP2532677A1
(en)
|
2005-10-21 |
2012-12-12 |
Novartis AG |
Human antibodies against il13 and therapeutic uses
|
|
WO2007049771A1
(ja)
|
2005-10-28 |
2007-05-03 |
Ono Pharmaceutical Co., Ltd. |
塩基性基を含有する化合物およびその用途
|
|
PT1961744E
(pt)
|
2005-11-18 |
2013-05-15 |
Ono Pharmaceutical Co |
Composto que contém um grupo básico e sua utilização
|
|
JP2009517474A
(ja)
*
|
2005-11-30 |
2009-04-30 |
シェーリング コーポレイション |
Ｃｃｒ５拮抗剤およびｃｘｃｒ４拮抗剤の組み合わせを含む組成物
|
|
GB0525671D0
(en)
|
2005-12-16 |
2006-01-25 |
Novartis Ag |
Organic compounds
|
|
GB0526244D0
(en)
|
2005-12-22 |
2006-02-01 |
Novartis Ag |
Organic compounds
|
|
WO2007084450A2
(en)
|
2006-01-18 |
2007-07-26 |
Schering Corporation |
Cannibinoid receptor modulators
|
|
JO2660B1
(en)
|
2006-01-20 |
2012-06-17 |
نوفارتيس ايه جي |
Pi-3 inhibitors and methods of use
|
|
RU2008140144A
(ru)
|
2006-03-10 |
2010-04-20 |
Оно Фармасьютикал Ко., Лтд. (Jp) |
Азотосодержащее гетероциклическое производное и фармацевтическое средство, включающее такое производное в качестве активного ингредиента
|
|
HRP20120494T1
(hr)
|
2006-04-21 |
2012-08-31 |
Novartis Ag |
Derivati purina za uporabu kao agonista adenozin a2a receptora
|
|
US8618122B2
(en)
|
2006-05-16 |
2013-12-31 |
Ono Pharmaceutical Co., Ltd. |
Compound having acidic group which may be protected, and use thereof
|
|
WO2008016006A1
(fr)
|
2006-07-31 |
2008-02-07 |
Ono Pharmaceutical Co., Ltd. |
Composé auquel un groupe cyclique est lié par une liaison spiro et son utilisation
|
|
DE602007013573D1
(de)
|
2006-08-16 |
2011-05-12 |
Hoffmann La Roche |
Nicht-nukleosidische reverse-transkriptase-hemmer
|
|
JP2010504933A
(ja)
|
2006-09-29 |
2010-02-18 |
ノバルティス アーゲー |
Ｐｉ３ｋ脂質キナーゼ阻害剤としてのピラゾロピリミジン
|
|
ES2550152T3
(es)
|
2006-12-13 |
2015-11-04 |
F. Hoffmann-La Roche Ag |
Derivados de 2-(piperidin-4-il)-4-fenoxi-o fenilamino-pirimidina como inhibidores no nucleósidos de transcriptasa inversa
|
|
GB0625523D0
(en)
*
|
2006-12-21 |
2007-01-31 |
Ge Healthcare Ltd |
In vivo imaging agents
|
|
AU2007342223B2
(en)
|
2007-01-10 |
2011-02-24 |
Irm Llc |
Compounds and compositions as channel activating protease inhibitors
|
|
US8536168B2
(en)
*
|
2007-03-15 |
2013-09-17 |
Novartis Ag |
Benzyl and pyridinyl derivatives as modulators of the hedgehog signaling pathway
|
|
BRPI0809646A2
(pt)
|
2007-03-29 |
2014-09-23 |
Hoffmann La Roche |
Compostod antivirais heterocíclicos
|
|
EP2332933A1
(en)
|
2007-05-07 |
2011-06-15 |
Novartis AG |
Epithelial sodium channel (ENaC) inhibitors
|
|
CA2687931C
(en)
|
2007-05-31 |
2016-05-24 |
Boehringer Ingelheim International Gmbh |
Ccr2 receptor antagonists and uses thereof
|
|
MX2010003621A
(es)
*
|
2007-10-01 |
2010-04-14 |
Hoffmann La Roche |
N-heterociclil biaril carboxamidas como antagonistas del receptor ccr.
|
|
BRPI0820669A2
(pt)
|
2007-12-10 |
2020-08-04 |
Novartis Ag |
compostos orgânicos
|
|
JP2011513317A
(ja)
*
|
2008-02-29 |
2011-04-28 |
シェーリング コーポレイション |
Ｈｉｖ感染を防止するための予防薬としてのｃｃｒ５アンタゴニストおよびｈｉｖの伝播を抑制する方法
|
|
US8268834B2
(en)
|
2008-03-19 |
2012-09-18 |
Novartis Ag |
Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme
|
|
WO2009128947A1
(en)
*
|
2008-04-17 |
2009-10-22 |
Concert Pharmaceuticals, Inc. |
Piperazine derivatives
|
|
KR20110040818A
(ko)
|
2008-06-10 |
2011-04-20 |
노파르티스 아게 |
상피 나트륨 채널 차단제로서의 피라진 유도체
|
|
US20100041663A1
(en)
|
2008-07-18 |
2010-02-18 |
Novartis Ag |
Organic Compounds as Smo Inhibitors
|
|
ES2551557T3
(es)
|
2008-12-19 |
2015-11-19 |
Boehringer Ingelheim International Gmbh |
Pirimidin-4-carboxamidas cíclicas como antagonistas del receptor CCR2 para el tratamiento de inflamaciones, asma y EPOC
|
|
ES2396023T3
(es)
|
2009-01-29 |
2013-02-18 |
Novartis Ag |
Bencimidazoles sustituidos para el tratamiento de astrocitomas
|
|
WO2010129351A1
(en)
|
2009-04-28 |
2010-11-11 |
Schepens Eye Research Institute |
Method to identify and treat age-related macular degeneration
|
|
US8389526B2
(en)
|
2009-08-07 |
2013-03-05 |
Novartis Ag |
3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
|
|
BR112012003262A8
(pt)
|
2009-08-12 |
2016-05-17 |
Novartis Ag |
compostos de hidrazona heterocíclica e seus usos para tratar câncer e inflamação
|
|
UA111579C2
(uk)
|
2009-08-17 |
2016-05-25 |
Інтеллікіне Ллк |
ГЕТЕРОЦИКЛІЧНІ ПОХІДНІ 2-АМІНОБЕНЗО[d]ОКСАЗОЛУ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЇХ ОСНОВІ ТА ЇХ ЗАСТОСУВАННЯ ДЛЯ ЛІКУВАННЯ ЗАХВОРЮВАННЯ, ПОВ'АНОГО З РІ3-КІНАЗОЮ
|
|
IN2012DN01453A
(enExample)
|
2009-08-20 |
2015-06-05 |
Novartis Ag |
|
|
AU2010310449A1
(en)
|
2009-10-22 |
2012-05-03 |
Vertex Pharmaceuticals Incorporated |
Compositions for treatment of cystic fibrosis and other chronic diseases
|
|
PL2513093T3
(pl)
|
2009-12-17 |
2015-03-31 |
Centrexion Therapeutics Corp |
Nowi antagoniści receptora CCR2 i ich zastosowanie
|
|
WO2011073155A1
(en)
*
|
2009-12-17 |
2011-06-23 |
Boehringer Ingelheim International Gmbh |
Novel antagonists for ccr2 and uses thereof
|
|
US8247436B2
(en)
|
2010-03-19 |
2012-08-21 |
Novartis Ag |
Pyridine and pyrazine derivative for the treatment of CF
|
|
WO2011141474A1
(en)
|
2010-05-12 |
2011-11-17 |
Boehringer Ingelheim International Gmbh |
Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
|
|
EP2569295B1
(en)
|
2010-05-12 |
2014-11-19 |
Boehringer Ingelheim International GmbH |
New ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
|
|
EP2571870B1
(en)
|
2010-05-17 |
2015-01-21 |
Boehringer Ingelheim International GmbH |
Ccr2 antagonists and uses thereof
|
|
US9018212B2
(en)
|
2010-05-25 |
2015-04-28 |
Boehringer Ingelheim International Gmbh |
Pyridazine carboxamides as CCR2 receptor antagonists
|
|
JP5721242B2
(ja)
|
2010-06-01 |
2015-05-20 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規ｃｃｒ２アンタゴニスト
|
|
BR112013000946B1
(pt)
|
2010-07-14 |
2020-09-08 |
Novartis Ag |
Compostos heterocíclicos agonistas de receptor de ip, seus usos, composição e combinação farmacêuticas
|
|
US8372845B2
(en)
|
2010-09-17 |
2013-02-12 |
Novartis Ag |
Pyrazine derivatives as enac blockers
|
|
WO2012107500A1
(en)
|
2011-02-10 |
2012-08-16 |
Novartis Ag |
[1, 2, 4] triazolo [4, 3 -b] pyridazine compounds as inhibitors of the c-met tyrosine kinase
|
|
WO2012116237A2
(en)
|
2011-02-23 |
2012-08-30 |
Intellikine, Llc |
Heterocyclic compounds and uses thereof
|
|
JP5786258B2
(ja)
|
2011-07-15 |
2015-09-30 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規かつ選択的なｃｃｒ２拮抗薬
|
|
WO2013024022A1
(en)
|
2011-08-12 |
2013-02-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for treatment of pulmonary hypertension
|
|
US8883819B2
(en)
|
2011-09-01 |
2014-11-11 |
Irm Llc |
Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
|
|
UY34329A
(es)
|
2011-09-15 |
2013-04-30 |
Novartis Ag |
Compuestos de triazolopiridina
|
|
WO2013038378A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Pyridine amide derivatives
|
|
WO2013038381A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Pyridine/pyrazine amide derivatives
|
|
JP6165733B2
(ja)
|
2011-09-16 |
2017-07-19 |
ノバルティス アーゲー |
Ｎ−置換ヘテロシクリルカルボキサミド類
|
|
WO2013038373A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Pyridine amide derivatives
|
|
CN103946221B
(zh)
|
2011-09-16 |
2016-08-03 |
诺华股份有限公司 |
用于治疗囊性纤维化的杂环化合物
|
|
US9174994B2
(en)
|
2011-11-23 |
2015-11-03 |
Intellikine, Llc |
Enhanced treatment regimens using mTor inhibitors
|
|
WO2013105058A1
(en)
|
2012-01-13 |
2013-07-18 |
Novartis Ag |
7,8- dihydropyrido [3, 4 - b] pyrazines as ip receptor agonists for the treatment of pulmonary arterial hypertension (pah) and related disorders
|
|
US9174985B2
(en)
|
2012-01-13 |
2015-11-03 |
Novartis Ag |
Salts of 7-(2,3-di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid as IP receptor agonists
|
|
EP2802582A1
(en)
|
2012-01-13 |
2014-11-19 |
Novartis AG |
Fused dihydropyrido [2,3 -b]pyrazines as ip receptor agonists for the treatment of pulmonary arterial hypertension (pah) and related disorders
|
|
EP2802583A1
(en)
|
2012-01-13 |
2014-11-19 |
Novartis AG |
Fused piperidines as ip receptor agonists for the treatment of pulmonary arterial hypertension (pah) and related disorders
|
|
AR089698A1
(es)
|
2012-01-13 |
2014-09-10 |
Novartis Ag |
Compuestos heterociclicos antagonistas del receptor ip
|
|
US9115129B2
(en)
|
2012-01-13 |
2015-08-25 |
Novartis Ag |
Substituted pyrido[2,3-B]pyrazines as IP receptor agonists
|
|
US8809340B2
(en)
|
2012-03-19 |
2014-08-19 |
Novartis Ag |
Crystalline form
|
|
MX371119B
(es)
|
2012-04-03 |
2020-01-17 |
Novartis Ag |
Productos de combinacion con los inhibidores de cinasa de tirosina y su uso.
|
|
US9227990B2
(en)
|
2012-10-29 |
2016-01-05 |
Cipla Limited |
Antiviral phosphonate analogues and process for preparation thereof
|
|
ES2637719T3
(es)
|
2013-02-13 |
2017-10-16 |
Novartis Ag |
Compuestos heterocíclicos agonistas del receptor IP
|
|
US9073921B2
(en)
|
2013-03-01 |
2015-07-07 |
Novartis Ag |
Salt forms of bicyclic heterocyclic derivatives
|
|
HK1219421A1
(zh)
|
2013-03-15 |
2017-04-07 |
因特利凯有限责任公司 |
激酶抑制剂的组合及其用途
|
|
TW201605450A
(zh)
|
2013-12-03 |
2016-02-16 |
諾華公司 |
Ｍｄｍ２抑制劑與ＢＲＡＦ抑制劑之組合及其用途
|
|
AU2014391610B2
(en)
|
2014-04-24 |
2018-01-25 |
Novartis Ag |
Pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
|
|
CA2945212A1
(en)
|
2014-04-24 |
2015-10-29 |
Novartis Ag |
Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
|
|
KR20160145780A
(ko)
|
2014-04-24 |
2016-12-20 |
노파르티스 아게 |
포스파티딜이노시톨 3-키나제 억제제로서의 아미노 피리딘 유도체
|
|
WO2016011658A1
(en)
|
2014-07-25 |
2016-01-28 |
Novartis Ag |
Combination therapy
|
|
US10195208B2
(en)
|
2014-07-31 |
2019-02-05 |
Novartis Ag |
Combination therapy
|
|
CN107108581B
(zh)
*
|
2014-08-21 |
2020-06-23 |
百时美施贵宝公司 |
作为强效rock抑制剂的回接苯甲酰胺衍生物
|
|
MX383744B
(es)
|
2015-07-02 |
2025-03-14 |
Centrexion Therapeutics Corp |
Citrato de (4-((3r,4r)-3-metoxitetrahidro-piran-4-ilamino)piperidin-1-il) (5-metil-6-(((2r, 6s)-6-(p-tolil)tetrahidro-2h-piran-2-il) metilamino) pirimidin-4-il) metanona.
|
|
US20200383960A1
(en)
|
2019-06-10 |
2020-12-10 |
Novartis Ag |
Pyridine and Pyrazine derivative for the Treatment of CF, COPD, and Bronchiectasis
|
|
KR20220052934A
(ko)
|
2019-08-28 |
2022-04-28 |
노파르티스 아게 |
치환 1,3-페닐 헤테로아릴 유도체 및 질환 치료에서의 이의 용도
|
|
TW202140550A
(zh)
|
2020-01-29 |
2021-11-01 |
瑞士商諾華公司 |
使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法
|
|
US11629196B2
(en)
|
2020-04-27 |
2023-04-18 |
Incelldx, Inc. |
Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions
|